Details of Drug-Drug Interaction
| Drug General Information (ID: DDIOFPCKWV) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Ranitidine (bismuth citrate) | Drug Info | Rilpivirine | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antiulcer Agents | Antiviral Agents | |||||||
| Structure | |||||||||
| Mechanism of Ranitidine (bismuth citrate)-Rilpivirine Interaction (Severity Level: Major) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Altered gastric pH Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Ranitidine (bismuth citrate) | Rilpivirine | |||||||
| Mechanism | Gastric alkalinizer | Gastric pH sensitive | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Gastric pH | ||||||||
| Factor Description | The normal pH range of gastric acid is between 1.5 and 3.5 and is highly acidic, consisting mainly of hydrochloric acid. Changes in the pH of the stomach can alter the absorption of drugs. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | To minimize the risk of reduced viral susceptibility and resistance development associated with subtherapeutic levels of rilpivirine, H2-receptor antagonists should be administered at least 12 hours before or 4 hours after the rilpivirine dose. | ||||||||

